[HTML][HTML] Haploidentical transplantation with post-transplant cyclophosphamide versus unrelated donor hematopoietic stem cell transplantation: a systematic review …
LJ Arcuri, MTM Aguiar, AAF Ribeiro… - Biology of Blood and …, 2019 - Elsevier
Hematopoietic stem cell transplantation (HSCT) is the standard treatment for patients with
high-risk hematologic malignancies. Only approximately 25% of siblings are HLA-matched …
high-risk hematologic malignancies. Only approximately 25% of siblings are HLA-matched …
[HTML][HTML] Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host …
AD Law, MQ Salas, W Lam, FV Michelis… - Biology of Blood and …, 2018 - Elsevier
Haploidentical hematopoietic stem cell transplantation (haploHSCT) with conditioning
regimens using post-transplant cyclophosphamide (PTCy) for peripheral blood stem cell …
regimens using post-transplant cyclophosphamide (PTCy) for peripheral blood stem cell …
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD
MQ Salas, S Prem, EG Atenafu, A Datt Law… - Bone Marrow …, 2020 - nature.com
The efficacy of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG)
in controlling GVHD has been previously reported. We aim to study the safety and efficacy of …
in controlling GVHD has been previously reported. We aim to study the safety and efficacy of …
[HTML][HTML] Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less …
Z Huang, H Yan, Y Teng, W Shi, L Xia - Frontiers in Immunology, 2022 - frontiersin.org
Currently, the graft-versus-host disease (GVHD) prophylaxis consists of an
immunosuppressive therapy mainly based on antithymocyte globulin (ATG) or post …
immunosuppressive therapy mainly based on antithymocyte globulin (ATG) or post …
Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) …
In the evolution of haploidentical hematopoietic stem cell transplantation (haplo-HSCT), In
vivo T-cell modulation with concomitant use of anti-thymocyte globulin (ATG) and high-dose …
vivo T-cell modulation with concomitant use of anti-thymocyte globulin (ATG) and high-dose …
Myeloablative haploidentical transplantation is superior to chemotherapy for patients with intermediate-risk acute myelogenous leukemia in first complete remission
M Lv, Y Wang, YJ Chang, XH Zhang, LP Xu… - Clinical Cancer …, 2019 - AACR
Purpose: Although myeloablative HLA haploidentical hematopoietic stem cell
transplantation (haplo-HSCT) following pretransplant anti-thymocyte globulin (ATG) and …
transplantation (haplo-HSCT) following pretransplant anti-thymocyte globulin (ATG) and …
Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study
BS Cho, GJ Min, S Park, SS Park… - American Journal of …, 2021 - Wiley Online Library
Despite comparable outcomes of haploidentical transplants (Haplo‐HSCT) with HLA‐
matched unrelated transplants (MUD‐HSCT) in retrospective comparisons, few studies have …
matched unrelated transplants (MUD‐HSCT) in retrospective comparisons, few studies have …
[HTML][HTML] Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual …
BS Cho, SA Yahng, GJ Min, S Park, SS Park… - … and Cellular Therapy, 2021 - Elsevier
Allogeneic hematopoietic stem cell transplantation (HSCT) remains the most effective
postremission therapy conferring the chance of cure for acute myeloid leukemia (AML) …
postremission therapy conferring the chance of cure for acute myeloid leukemia (AML) …
[HTML][HTML] Laser-induced greenish-blue photoluminescence of mesoporous silicon nanowires
Solid silicon nanowires and their luminescent properties have been widely studied, but
lesser is known about the optical properties of mesoporous silicon nanowires (mp-SiNWs) …
lesser is known about the optical properties of mesoporous silicon nanowires (mp-SiNWs) …
Safety and efficacy of haploidentical peripheral blood stem cell transplantation for myeloid malignancies using post-transplantation cyclophosphamide and anti …
MQ Salas, AD Law, W Lam, Z Al-Shaibani… - Clinical Hematology …, 2019 - Springer
Haploidentical stem cell transplantation (haploSCT) has greatly improved access to curative
treatment for myeloid malignancies in patients without suitable matched sibling/unrelated …
treatment for myeloid malignancies in patients without suitable matched sibling/unrelated …